An Analysis Finds Shingrix is Highly Effective for Preventing Shingles in Seniors
A real-world analysis shows Shingrix effectively prevents shingles in adults over the age of 65, including immunocompromised people.
Shingles is a viral infection that occurs when the varicella-zoster virus (VZV) reactivates in the body, presenting as a rash with painful blisters.
According to the CDC, shingles is more common in adults over 50, with 5-30% of patients experiencing post-herpetic neuralgia (PHN), a long-lasting nerve pain.
- Shingrix is a recombinant zoster vaccine (RZV) manufactured by GSK.
- Two doses of Shingrix provide better protection than one.
Shingrix is effective in preventing shingles in adults over 65, including immunocompromised adults, with two doses being more effective than one.
Author's summary: Shingrix prevents shingles in seniors.